XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.

U.S. Biomea Fusion, Enphase Energy, Perion Network



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>U.S. RESEARCH ROUNDUP-Biomea Fusion, Enphase Energy, Perion Network</title></head><body>

June 11 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Biomea Fusion, Enphase Energy and Perion Network, on Tuesday.


HIGHLIGHTS


* Biomea Fusion Inc BMEA.O: Truist Securities cuts to hold from buy

* Cleveland-Cliffs Inc CLF.N: JP Morgan cuts to neutral from overweight

* Enphase Energy Inc ENPH.O: HSBC raises to buy from hold

* Perion Network Ltd PERI.O: Needham cuts to hold from buy

* TD Synnex Corp SNX.N: RBC raises target price to $135 from $118

Following is a summary of research actions on US companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.


* Addus Homecare Corp ADUS.O: Raymond James raises target price to $125 from $115

* Aflac Inc AFL.N: Raymond James raises target price to $94 from $88

* AIG AIG.N: BofA Global Research raises price objective to $84 from $82

* Alphabet Inc GOOGL.O: Evercore ISI raises target price to $225 from $220

* Apple Inc AAPL.O: D.A. Davidson raises target price to $230 from $200

* Apple Inc AAPL.O: D.A. Davidson raises to buy from neutral

* AZZ Inc AZZ.N: Noble Capital raises to outperform

* BAT BTI.N: Morgan Stanley cuts target price to $34 from $35.5

* Biomea Fusion Inc BMEA.O: Truist Securities cuts to hold from buy

* Children's Place Inc PLCE.O: UBS cuts target price to $12 from $24

* Cleveland-Cliffs Inc CLF.N: JP Morgan cuts to neutral from overweight

* Cleveland-Cliffs Inc CLF.N: JP Morgan cuts to target price to $17 from $23

* Comstock Resources Inc CRK.N: Gerdes Energy Research cuts to neutral from buy

* Confluent Inc CFLT.O: Evercore ISI initiates coverage with outperform rating; PT $35

* Corbus Pharmaceuticals Holdings Inc CRBP.O: RBC raises target price to $82 from $77

* Corecivic Inc CXW.N: Wedbush cuts to neutral from outperform; cuts PT to $14 from $19

* Darden Restaurants Inc DRI.N: Wedbush cuts target price to $170 from $181

* Dave & Buster's Entertainment Inc PLAY.O: Truist Securities cuts PT to $67 from $78

* Eli Lilly LLY.N: Jefferies raises target price to $994 from $957

* Enliven Therapeutics Inc ELVN.O: Baird initiates coverage with outperform rating; PT $32

* Enphase Energy Inc ENPH.O: HSBC raises target price to $166 from $104

* Enphase Energy Inc ENPH.O: HSBC raises to buy from hold

* Factset Research Systems Inc FDS.N: UBS cuts target price to $455 from $480

* Ford Motor Co F.N: HSBC raises target price to $13 from $11.3

* Freshpet Inc FRPT.O: Benchmark raises target price to $150

* FTAI Aviation Ltd FTAI.O: Citigroup raises target price to $99 from $81

* Fuelcell Energy Inc FCEL.O: Jefferies cuts target price to $1.11 from $1.25

* GE Vernova GEV.N: Citigroup initiates coverage with neutral rating; PT $183

* General Motors Co GM.N: HSBC raises target price to $56 from $48

* Geron Corp GERN.O: Barclays initiates coverage with overweight rating and PT $9

* Gladstone Land LAND.O: Alliance Global Partners initiates coverage with buy rating; PT $16

* Goosehead Insurance Inc GSHD.O: BofA Global Research raises PT to $37 from $35

* Illumina Inc ILMN.O: Evercore ISI cuts target price to $175 from $195

* KKR & Co Inc KKR.N: Deutsche Bank raises target price to $129 from $120

* Longboard Pharmaceuticals Inc LBPH.O: B. Riley raises target price to $36 from $30

* Manpowergroup MAN.N: Exane BNP Paribas raises to outperform from underperform

* Marriott International Inc MAR.O: UBS raises target price to $267 from $259

* Micron Technology Inc MU.O: Bernstein raises target price to $140 from $105

* Nucor Corp NUE.N: JP Morgan cuts target price to $180 from $190

* Nvidia Corp NVDA.O: Evercore ISI adjusts PT to $131 from $1310 to reflect 10-for-1 stock split

* Nvidia Corp NVDA.O: Oppenheimer adjusts PT to $150 from $110 to reflect 10-for-1 stock split

* Oscar Health Inc OSCR.N: Raymond James raises PT to $30 from $25

* Par Technology Corp PAR.N: Benchmark raises PT to $61 from $59

* Par Technology Corp PAR.N: Needham raises PT to $57 from $53

* Perion Network Ltd PERI.O: Needham cuts to hold from buy

* Powerschool Holdings PWSC.N: Raymond James cuts to market perform from outperform

* Prokidney Corp PROK.O: Jefferies cuts target price to $6 from $15

* Redwood Trust RWT.N: Jonestrading initiates coverage with buy rating; PT $7.25

* RLJ Lodging Trust RLJ.N: Baird cuts target price to $12 from $13

* Robert Half RHI.N: Exane BNP Paribas raises to outperform from underperform

* Skye Bioscience Inc SKYE.O: Oppenheimer cuts target price to $21 from $25

* Staar Surgical Co STAA.O: BTIG raises to buy from neutral

* Targa Resources Corp TRGP.N: UBS raises target price to $147 from $116

* TD Synnex Corp SNX.N: RBC raises target price to $135 from $118

* Vertex Pharmaceuticals Inc VRTX.O: RBC cuts PT to $421 from $424

* Walmart WMT.N: HSBC raises target price to $81 from $70

* Western Digital Corp WDC.O: Susquehanna raises target price to $88 from $80

* Yext Inc YEXT.N: D.A. Davidson cuts target price to $5.5 from $7.25


(Compiled by Bengaluru Newsroom)

</body></html>

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.